Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

UNC study provides insight into mechanism of CHD4-related heart defects

Heart defects are the most common type of birth defect, and can be caused by mutations in the gene CHD4. Researchers at the UNC School of Medicine have now revealed key molecular details of how CHD4 mutations lead to heart defects.

12 Jun 2018

Researchers discover new method to predict chance of cancer treatment success

Doctors are increasingly fighting cancer by stimulating patients' immune systems. SNSF-supported researchers have now discovered a method for predicting the likelihood of treatment success.

12 Jun 2018

Research identifies new genetic variations that could indicate higher prostate cancer risk

As the result of a six-year long research process, Fredrick R. Schumacher, PhD, a cancer epidemiology researcher at Case Western Reserve University School of Medicine, and an international team of more than 100 colleagues have identified 63 new genetic variations that could indicate higher risk of prostate cancer in men of European descent.

12 Jun 2018

New blood test better than having a needle inserted into the eye

People diagnosed with a deadly form of cancer will no longer face the prospect of having a needle inserted into their eye thanks to a new blood test developed by Edith Cowan University researchers.

12 Jun 2018

Translate Bio collaborates with Sanofi to develop mRNA vaccines for infectious diseases

Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to develop mRNA vaccines for up to five undisclosed infectious disease pathogens.

11 Jun 2018

Biotheranostics presents key data for CancerTYPE ID and Breast Cancer Index at ASCO 2018

Biotheranostics, Inc. announces new data from studies for both of its proprietary molecular diagnostic tests, CancerTYPE ID and Breast Cancer Index to be presented on Saturday, June 2nd and Monday, June 4th at the annual meeting of the American Society of Clinical Oncology in Chicago.

8 Jun 2018

New analytical method improves diagnosis and monitoring of cancer

Ten times more sensitive than current techniques, the technique allows, from a blood serum sample, to simultaneously detect different biomarkers related to cancer.

8 Jun 2018

UC San Diego Health joins OpenNotes: Patients can now read their medical notes

Ever wonder what your doctor writes about your office visit? Patients at UC San Diego Health can now read the medical notes signed by their primary care physician. This move toward transparency is part of an international trend to make patients feel more in control of their health care.

8 Jun 2018

Researchers discover new therapy combination that may help treat ovarian cancer

Researchers at The University of Kansas Cancer Center have discovered a therapy combination that may be helpful in the treatment of certain types of ovarian cancer.

8 Jun 2018

Research project aims to study opioid prescriptions after cesarean delivery and hysterectomy

Each year, approximately 1.8 million women will have a cesarean delivery or hysterectomy. While opioids are the mainstay treatment for acute pain after these surgeries, most women use only a fraction of the opioids prescribed and do not properly dispose of unused drugs

7 Jun 2018

NCI cancer centers come together to discuss ways to eliminate HPV Cancers

The University of New Mexico Comprehensive Cancer Center has joined the other 69 cancer centers designated by the National Cancer Institute to issue a statement urging increased vaccination for human papillomavirus.

7 Jun 2018

Colorado researchers suggest new combination therapy for advanced head and neck cancer

The five-year survival rate for locally-advanced head and neck cancer is only 46 percent, even with treatments including surgery, radiation, chemotherapy and/or genetically targeted treatments such as cetuximab.

7 Jun 2018

Researchers’ attempt to combine immunotherapy drugs have turned out to be failure

A class of immunotherapy drugs called checkpoint inhibitors has shown great promise against cancer in some patients.

7 Jun 2018

Study finds how colon cancer alters its genes to escape the immune system

A UCLA-led study has found how colon cancer alters its genes during development in order to avoid detection by the immune system, creating a specific genetic imprint in the process.

6 Jun 2018

Zebrafish may hold answers to how tumors develop in childhood muscle cancer

A popular aquarium fish may hold answers to how tumors form in a childhood cancer.

6 Jun 2018

Researchers explore targeted second-line treatment for colorectal cancer

Targeted therapy with anti-VEGF and anti-EGFR antibodies both improve outcomes when added to chemotherapy in the treatment of colorectal cancer. However, some previous studies suggested the combination of the two antibodies may have a negative interaction.

5 Jun 2018

IONTAS collaborates with LG Chem to discover antibodies for treating cancer

IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, today announced it has signed a collaboration agreement with Korean-based LG Chem, Ltd. for the discovery of therapeutic antibodies targeting undisclosed targets for use in the treatment of cancers.

5 Jun 2018

More frequent post treatment monitoring does not improve survival in prostate cancer patients, finds study

Chemotherapy may provide no benefit for breast cancer in some cases

In a new study a team of researchers have found that chemotherapy can be completely skipped in early stage breast cancer patients provided certain genetic tests of the tumours are made to assess the risk.

5 Jun 2018

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

A novel positron emission tomography imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease, which includes ulcerative colitis and Crohn's disease.

4 Jun 2018

Oncology News and Research

Further Reading

UNC study provides insight into mechanism of CHD4-related heart defects

Researchers discover new method to predict chance of cancer treatment success

Research identifies new genetic variations that could indicate higher prostate cancer risk

New blood test better than having a needle inserted into the eye

Translate Bio collaborates with Sanofi to develop mRNA vaccines for infectious diseases

Biotheranostics presents key data for CancerTYPE ID and Breast Cancer Index at ASCO 2018

New analytical method improves diagnosis and monitoring of cancer

UC San Diego Health joins OpenNotes: Patients can now read their medical notes

Researchers discover new therapy combination that may help treat ovarian cancer

Research project aims to study opioid prescriptions after cesarean delivery and hysterectomy

NCI cancer centers come together to discuss ways to eliminate HPV Cancers

Colorado researchers suggest new combination therapy for advanced head and neck cancer

Researchers’ attempt to combine immunotherapy drugs have turned out to be failure

Study finds how colon cancer alters its genes to escape the immune system

Zebrafish may hold answers to how tumors develop in childhood muscle cancer

Researchers explore targeted second-line treatment for colorectal cancer

IONTAS collaborates with LG Chem to discover antibodies for treating cancer

More frequent post treatment monitoring does not improve survival in prostate cancer patients, finds study

Chemotherapy may provide no benefit for breast cancer in some cases

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News